EUVIMEDEUVIMED entdecken
Crossref

Assessment of antiemetic potential of schaftoside through modulation of dopaminergic, serotonergic and muscarinic signaling pathways: in vivo and in silico investigations

Md Shakil Ahmmed, Rakib Hossan, Tawfik Rakaiyat Ripu, Towfiqur Rahman, Mohammad Y Alshahrani, Emon Mia, Proma Mandal, Md Sakib Al Hasan, Md Mizanur Rahaman, Muhammad Torequl Islam

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-025-04714-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Md Shakil Ahmmed und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, 8100, Bangladesh. Hauptthemen laut MEDLINE: Antiemetics, Vomiting, Receptors, Muscarinic, Receptors, Serotonin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Schaftoside (SCF), a natural flavonoid present in numerous plants, exhibits diverse physiological and pharmacological properties. This study explores the antiemetic effects of SCF in response to copper sulfate pentahydrate (CuSO4.5H2O)-induced vomiting, employing both in vivo and in silico methods. To induce emesis in chicks, CuSO4.5H2O (50 mg/kg) was administered orally. SCF was tested at doses of 5, 10, and 20 mg/kg and compared to standard antiemetics domperidone (DOM-6 mg/kg), ondansetron (OND-5 mg/kg), and hyoscine (HYO-21 mg/kg). The control group received a vehicle, while additional groups received drug combinations to assess synergy or antagonism. Molecular docking and ligand-receptor interactions targeting D2, D3, 5HT3, and M1-M5 receptors were analyzed, and SCF's pharmacokinetics (PKs), drug-likeness, and toxicity were evaluated. SCF showed antiemetic effects at higher doses (20 mg/kg), reducing retching (1.8 ± 0.41) and increasing latency (67.6 ± 2.63 s) compared to the vehicle. SCF also enhanced the efficacy of DOM, OND and HYO. The molecular docking results indicated that SCF binds strongly, particularly at M4 (- 9.7 kcal/mol), with higher affinity than all reference drugs except D3. Our findings indicate that SCF exerts potent antiemetic effects by modulating the D2, 5HT3 and muscarinic receptor pathways. PKs and toxicity profiling revealed that SCF possesses favorable drug-likeness characteristics, good water solubility, moderate skin permeability, favorable metabolic and excretory characteristics as well as promising safety profile. Despite some lacking in PKs properties, its safety profile and efficacy in behavioral models support SCF as a promising candidate for antiemetic drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntiemeticsVomitingReceptors, MuscarinicReceptors, SerotoninGlycosidesAnimalsMolecular Docking SimulationSignal TransductionChickensMaleDose-Response Relationship, DrugComputer Simulation

Stichwörter der Autor:innen

EmesisFlavonoidMolecular dockingSchaftosideVomiting

Substanzen

AntiemeticsReceptors, MuscarinicReceptors, SerotoninGlycosides

Autor:innen und Institutionen

  • Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, 8100, Bangladesh.
  • Central Labs, King Khalid University, P.O. Box 61413, 9088, Abha, Saudi Arabia.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, P.O. Box 61413, 9088, Abha, Saudi Arabia.
  • Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, 8100, Bangladesh. mdsakibalhasan192412@gmail.com.
  • Biomedical Sciences and Molecular Biology, College of Medicine and Dentistry, James Cook University, Townsville, QLD, 4811, Australia.
  • Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, 8100, Bangladesh. dmt.islam@gstu.edu.bd.

Zitieren

APA

Ahmmed, M. S., Hossan, R., Ripu, T. R., Rahman, T., Alshahrani, M. Y., Mia, E., Mandal, P., Al Hasan, M. S., Rahaman, M. M., & Islam, M. T. (2026). Assessment of antiemetic potential of schaftoside through modulation of dopaminergic, serotonergic and muscarinic signaling pathways: in vivo and in silico investigations. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04714-7

Vancouver

Ahmmed MS, Hossan R, Ripu TR, Rahman T, Alshahrani MY, Mia E, et al. Assessment of antiemetic potential of schaftoside through modulation of dopaminergic, serotonergic and muscarinic signaling pathways: in vivo and in silico investigations. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-025-04714-7

BibTeX
@article{Ahmmed2026,
  author = {Ahmmed, Md Shakil and Hossan, Rakib and Ripu, Tawfik Rakaiyat and Rahman, Towfiqur and Alshahrani, Mohammad Y and Mia, Emon and Mandal, Proma and Al Hasan, Md Sakib and Rahaman, Md Mizanur and Islam, Muhammad Torequl},
  title = {Assessment of antiemetic potential of schaftoside through modulation of dopaminergic, serotonergic and muscarinic signaling pathways: in vivo and in silico investigations},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-025-04714-7}
}
Kostenlos starten →